Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2018

01-12-2018 | Colorectal Cancer

A New N Staging System for Colorectal Cancer in the Era of Extended Lymphadenectomy

Authors: Eiji Shinto, MD, Jin-ichi Hida, MD, Hideyuki Ike, MD, Hirotoshi Kobayashi, MD, Yojiro Hashiguchi, MD, Kazuo Hase, MD, Hideki Ueno, MD, Kenichi Sugihara, MD

Published in: Annals of Surgical Oncology | Issue 13/2018

Login to get access

Abstract

Background

Complete mesocolic excision is becoming popular in colon cancer surgery in Western countries, and in the tumor-node-metastasis (TNM) classification of rectal cancer, a part of the lateral pelvic lymph nodes is classified as regional. However, the appropriateness of TNM staging according to the assessment of nodal status exclusively by extended lymphadenectomy remains unclear.

Patients and Methods

Using a nationwide multicenter database in Japan, we retrospectively analyzed 6866 patients with stage III colorectal cancer (CRC) treated with extended (D3) dissection. First, the best cutoff values for the number of metastatic nodes were explored. Second, the utility of the metastatic status of the main lymph nodes (i.e., at the origin of the feeding artery) and the lateral pelvic lymph nodes (“jN3” category in the Japanese staging system) as N staging criteria was evaluated. The modified N staging system that had the best risk stratification power was determined according to the Akaike information criterion (AIC).

Results

Excellent performance was noted when the number of metastatic nodes was categorized by cutoff values of “3/4” and “6/7.” Categorization of nodal metastasis was proven the most clinically efficacious when classified as modified-N1 (N1 and jN3-negative), modified-N2a (N2a and jN3-negative), and modified-N2b (N2b and/or jN3-positive; AIC, 22,810.8), rather than the classification based on the TNM (AIC, 22,849.2) or Japanese staging system (AIC, 22,811.1).

Conclusions

We structured a modified N staging system according to the number and extent of lymph node metastases. The modified system may be used in stage III cases for precise risk stratification.
Appendix
Available only for authorised users
Literature
1.
go back to reference Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954; 139:846–52.CrossRef Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954; 139:846–52.CrossRef
2.
go back to reference Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer. 1974; 34:1278–92.CrossRef Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer. 1974; 34:1278–92.CrossRef
3.
go back to reference Brierley JD, Gospodarowicz MK, Wittekind C, eds. TNM Classification of Malignant Tumors. 8th Edition. Hoboken: Wiley-Blackwell; 2017. Brierley JD, Gospodarowicz MK, Wittekind C, eds. TNM Classification of Malignant Tumors. 8th Edition. Hoboken: Wiley-Blackwell; 2017.
4.
go back to reference JSCCR. Japanese Classification of Colorectal Carcinoma Second English Edition ed. Tokyo: Kanehara; 2009. JSCCR. Japanese Classification of Colorectal Carcinoma Second English Edition ed. Tokyo: Kanehara; 2009.
5.
go back to reference Vaccaro CA, Bonadeo FA, Benati ML, et al. Colorectal cancer staging: reappraisal of N/PN classification. Dis Colon Rectum. 2004; 47:66–9.CrossRef Vaccaro CA, Bonadeo FA, Benati ML, et al. Colorectal cancer staging: reappraisal of N/PN classification. Dis Colon Rectum. 2004; 47:66–9.CrossRef
6.
go back to reference Kendal WS. Lymph node-based prognostics: limitations with individualized cancer treatment. Am J Clin Oncol. 2006; 29:298–304.CrossRef Kendal WS. Lymph node-based prognostics: limitations with individualized cancer treatment. Am J Clin Oncol. 2006; 29:298–304.CrossRef
7.
go back to reference Akagi Y, Fukushima T, Mizobe T, et al. Challenges in staging systems for colorectal cancer: clinical significance of metastatic lymph node number in colorectal cancer and mesorectal extension in rectal cancer. Digestion. 2010; 82:192–7.CrossRef Akagi Y, Fukushima T, Mizobe T, et al. Challenges in staging systems for colorectal cancer: clinical significance of metastatic lymph node number in colorectal cancer and mesorectal extension in rectal cancer. Digestion. 2010; 82:192–7.CrossRef
8.
go back to reference Fukushima T, Akagi Y, Murakami H, et al. Estimation of the number of metastatic lymph nodes in Dukes’ C colorectal cancer. Anticancer Res. 2013; 33:2949–55.PubMed Fukushima T, Akagi Y, Murakami H, et al. Estimation of the number of metastatic lymph nodes in Dukes’ C colorectal cancer. Anticancer Res. 2013; 33:2949–55.PubMed
9.
go back to reference Hermanek P, Guggenmoos-Holzmann I, Gall FP. Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification. Dis Colon Rectum. 1989; 32:593–9.CrossRef Hermanek P, Guggenmoos-Holzmann I, Gall FP. Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification. Dis Colon Rectum. 1989; 32:593–9.CrossRef
10.
go back to reference Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the Dukes’ C class of colorectal cancer. An analysis of the NSABP clinical trials. Ann Surg. 1986; 203:115–22.CrossRef Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the Dukes’ C class of colorectal cancer. An analysis of the NSABP clinical trials. Ann Surg. 1986; 203:115–22.CrossRef
11.
go back to reference Kobayashi H, Ueno H, Hashiguchi Y, Mochizuki H. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer. Surgery. 2006; 139:516–22.CrossRef Kobayashi H, Ueno H, Hashiguchi Y, Mochizuki H. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer. Surgery. 2006; 139:516–22.CrossRef
12.
go back to reference Hida J, Okuno K, Yasutomi M, et al. Number versus distribution in classifying regional lymph node metastases from colon cancer. J Am Coll Surg. 2005; 201:217–22.CrossRef Hida J, Okuno K, Yasutomi M, et al. Number versus distribution in classifying regional lymph node metastases from colon cancer. J Am Coll Surg. 2005; 201:217–22.CrossRef
13.
go back to reference Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer. 1994; 73:2076–82.CrossRef Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer. 1994; 73:2076–82.CrossRef
14.
go back to reference Shinto E, Hida J, Kobayashi H, et al. Prominent information of jN3-positive in stage III colorectal cancer removed by D3 dissection: retrospective analysis of 6866 patients from a multi-institutional database in Japan. Dis Colon Rectum. 2018; 61:447–53.CrossRef Shinto E, Hida J, Kobayashi H, et al. Prominent information of jN3-positive in stage III colorectal cancer removed by D3 dissection: retrospective analysis of 6866 patients from a multi-institutional database in Japan. Dis Colon Rectum. 2018; 61:447–53.CrossRef
15.
go back to reference Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015; 20:207–39.CrossRef Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015; 20:207–39.CrossRef
16.
go back to reference Wang SJ, Lemieux A, Kalpathy-Cramer J, et al. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol. 2011; 29:4627–32.CrossRef Wang SJ, Lemieux A, Kalpathy-Cramer J, et al. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol. 2011; 29:4627–32.CrossRef
17.
go back to reference Ueno H, Mochizuki H, Akagi Y, et al. Optimal colorectal cancer staging criteria in TNM classification. J Clin Oncol. 2012; 30:1519–26.CrossRef Ueno H, Mochizuki H, Akagi Y, et al. Optimal colorectal cancer staging criteria in TNM classification. J Clin Oncol. 2012; 30:1519–26.CrossRef
18.
go back to reference Akaike H. Information theory and extension of the maximum likelihood principle. In: Kotz S, Johnson NL, eds. Breakthroughs in Statistics Vol 1. Foundations and Basic Theory. New York: Springer-Verlag; 1973:610–24. Akaike H. Information theory and extension of the maximum likelihood principle. In: Kotz S, Johnson NL, eds. Breakthroughs in Statistics Vol 1. Foundations and Basic Theory. New York: Springer-Verlag; 1973:610–24.
19.
go back to reference Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 2012; 13:616–21.CrossRef Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 2012; 13:616–21.CrossRef
20.
go back to reference Fujita S, Mizusawa J, Kanemitsu Y, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg. 2017; 266:201–7.CrossRef Fujita S, Mizusawa J, Kanemitsu Y, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg. 2017; 266:201–7.CrossRef
21.
go back to reference Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010; 28:264–71.CrossRef Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010; 28:264–71.CrossRef
22.
go back to reference Ishihara S, Kawai K, Tanaka T, et al. Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Dis Colon Rectum. 2017; 60:469–76.CrossRef Ishihara S, Kawai K, Tanaka T, et al. Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Dis Colon Rectum. 2017; 60:469–76.CrossRef
23.
go back to reference Kim HJ, Choi GS, Park JS, et al. Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer. Oncotarget. 2017; 8:100724–33.PubMedPubMedCentral Kim HJ, Choi GS, Park JS, et al. Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer. Oncotarget. 2017; 8:100724–33.PubMedPubMedCentral
Metadata
Title
A New N Staging System for Colorectal Cancer in the Era of Extended Lymphadenectomy
Authors
Eiji Shinto, MD
Jin-ichi Hida, MD
Hideyuki Ike, MD
Hirotoshi Kobayashi, MD
Yojiro Hashiguchi, MD
Kazuo Hase, MD
Hideki Ueno, MD
Kenichi Sugihara, MD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6786-x

Other articles of this Issue 13/2018

Annals of Surgical Oncology 13/2018 Go to the issue